Breast Cancer Clinical Trial

Comorbidities And Reducing inEquitieS

Summary

Black cancer patients tend to have worse outcomes than White cancer patients. Some of this disparity may be due to comorbidities. The purpose of this study is to improve management of co-morbidities among cancer patients in order to improve cancer outcomes and improve health equity.

Comorbidities such as diabetes and hypertension can complicate cancer treatment or can make it difficult to reach optimal health after treatment. This study will offer additional support and tools to manage cancer patient's health needs. First, the study will use a mobile health application, managed by a company called Welldoc, to monitor patient progress in real time and to provide ongoing guidance. Second, the study will connect patients with a Community Health Worker who will speak with them weekly to discuss self-care information, including medical scheduling or appointment needs, and assist with daily self-monitoring of blood pressure and/or blood glucose monitoring. Lastly, an oncology nurse will monitor reported health and triage any medical needs and whether additional medical care is needed.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Black women with a diagnosis of stage 0-IV breast cancer and within a month of treatment initiation or with 6+ months of treatment left OR Black men with a history of prostate cancer who are on long-term androgen deprivation therapy;
Blood pressure >=120/80 OR diagnosis of diabetes
Individuals who develop these conditions during treatment such as those scheduled to initiate steroid-containing chemotherapy or targeted PI3K inhibitor therapies
Access to a smartphone and/or internet for the duration of the study.
Can understand and communicate in English

Exclusion Criteria:

- Unwilling to participate in a 6-month study

Study is for people with:

Breast Cancer

Estimated Enrollment:

100

Study ID:

NCT04836221

Recruitment Status:

Recruiting

Sponsor:

Medstar Health Research Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

MedStar Washington Hospital Center
Washington District of Columbia, 20010, United States More Info
Andrea Lopez
Contact
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

100

Study ID:

NCT04836221

Recruitment Status:

Recruiting

Sponsor:


Medstar Health Research Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider